The DOI matches its Crossref record.
Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
Open accessAbstract
Summary: Background : Azathioprine therapy is discontinued in one‐third of patients with inflammatory bowel disease because of toxicity or a lack of clinical response. Patients with thiopurine methyltransferase (TPMT) deficiency are intolerant to azathioprine, whilst carriers are at increased risk of side‐effects. Aim : To evaluate the importance of TPMT activity in the management of azathioprine therapy in inflammatory bowel disease. Methods : Clinical response, adverse effects and haematological parameters were determined and correlated with TPMT enzyme activity and genotype in 106 patients with inflammatory bowel disease. Results : Ninety‐six patients had high TPMT activity, and 10 had intermediate activity. Nineteen patients (18%) were intolerant to azathioprine. Fifteen (16%) of those with high TPMT activity were intolerant, compared with five (50%) with intermediate activity [odds ratio (OR), 5.4; 95% confidence interval (CI), 1.5–19.8]. Complete remission was achieved in 63% of cases, and complete or partial remission in 79%. Interestingly, very high TPMT activity (> 14 units/mL red blood cells) was significantly associated with non‐response, irrespective of the time on azathioprine (OR, 0.21; 95% CI, 0.07–0.68). TPMT gene mutations correlated with TPMT activity. Conclusions : Inflammatory bowel disease patients with intermediate TPMT activity have an increased risk of azathioprine toxicity. Conversely, very high TPMT activity predicts treatment failure. TPMT genotype predicted TPMT phenotype in this study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease
Ruemmele, F. M., Veres, G., Kolho, K. L., Griffiths, A., Levine, A., Escher, J. C., Amil Dias, J., Barabino, A., Braegger, C. P., Bronsky, J., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.04.005 · Cited by 1,083
Marinaki, A. M., Ansari, A., Duley, J. A., Arenas, M., Sumi, S., Lewis, C. M., Shobowale-Bakre, E.-M., Escuredo, E., Fairbanks, L. D., & Sanderson, J. D. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00006 · Cited by 323
Self-citation
Metadata
- Authors
- Ansari, A., Hassan, C., Duley, J., Marinaki, A., Shobowale‐Bakre, E. ‐., Seed, P., Meenan, J., Yim, A., & Sanderson, J.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2002-09-19
- Volume
- 16
- Issue
- 10
- Pages
- 1743-1750
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1964947822
- Cited by
- 249
- References
- 0
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. https://app.cochat.ai/papers/10.1046/j.1365-2036.2002.01353.x
- The paper
- Ansari, A., Hassan, C., Duley, J., Marinaki, A., Shobowale‐Bakre, E. ‐., Seed, P., Meenan, J., Yim, A., & Sanderson, J. (2002). Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2002.01353.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.